EMA — authorised 20 June 2019
- Marketing authorisation holder: PFIZER EUROPE MA EEIG
- Status: approved
🇪🇺 Talzenna in European Union
EMA authorised Talzenna on 20 June 2019
Marketing authorisation
Talzenna in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Talzenna approved in European Union?
Yes. EMA authorised it on 20 June 2019.
Who is the marketing authorisation holder for Talzenna in European Union?
PFIZER EUROPE MA EEIG holds the EU marketing authorisation.